NEW YORK, Sept. 22 /PRNewswire/ -- Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy, has announced an exclusive partnership with the Joanna Briggs Institute (JBI), a recognized global leader in evidence-based healthcare resources based at the University of Adelaide, Australia, as part of an expansion of the nursing, allied health, and medical content delivered to customers of products in the Lippincott Williams & Wilkins (LWW) journals and Ovid brands.
Under this agreement, LWW and Ovid will deliver JBI COnNECT+ (Clinical Online Network of Evidence for Care and Therapeutics) to its global clinical point-of-care services market immediately, with an expansion into all markets beginning in October 2012. JBI COnNECT+ is JBI's web portal for content and user tools designed to assist health care providers to access, appraise, and use evidence-based information in clinical decision-making processes.
In addition, LWW and Ovid are now the exclusive global channels for online access to an expanded version of JBI's PACEsetterS publication, which brings the latest advances in evidence-based practice information, audit and implementation for healthcare providers and consumers, as well as the latest news from JBI collaborating entities to JBI members and the entire healthcare community.
This is the first step in a deeper long-term collaboration between JBI, LWW, and Ovid focusing on opportunities to further develop and integrate JBI content and tools into multiple Wolters Kluwer Health destinations, including Lippincott's NursingCenter.com, LWW online journals, and institutionally via OvidSP and Nursing@Ovid.
"LWW and Ovid are delighted to be partnering with JBI," said Karen Abramson, President & CEO of Wolters Kluwer Health Medical Research. "The Joanna Briggs Institute is the acknowledged leader in translational research in clinical care and therapeutics, including the creation of systematic reviews, evidence summaries and the tools needed to embed these into healthcare service delivery processes. Both of our organizations are committed to offering evidence-based, best practice resources to nurses, physicians and healthcare professionals worldwide to assist them in providing health care, advice and assistance at point of contact with their patients or clients. We look forward to making these invaluable resources accessible to even more healthcare providers in the global healthcare community, delivered when they want it, in the format they want it in."
"After an extensive review of JBI's current and future positioning, we are delighted to be partnering with Wolters Kluwer Health," said Professor Alan Pearson, Executive Director, The Joanna Briggs Institute and Professor of Evidence Based Healthcare at the University of Adelaide. "JBI's mission has always included the improvement of patient outcomes by ensuring that healthcare professionals have access at point-of-care to the best available international evidence. We have major plans for the addition of new, previously unpublished resources in PACEsetterS and a partnership with Wolters Kluwer Health helps us to reach more healthcare professionals than ever before and to strengthen and accelerate the growth of core content and tools delivered to our current and future members."
About the Joanna Briggs Institute
The Joanna Briggs Institute (JBI) is an internationally renowned research and development unit of the University of Adelaide, Australia. The Institute collaborates internationally with over 60 entities and groups located across the world to improve health care outcomes globally.
The JBI approach to evidence-based health care is unique. JBI considers evidence-based health care at point-of-contact with patients or clients to be reliant on the research evidence, the context in which care is delivered, individual patient/client preference and the professional judgment of the health professional.
JBI COnNECT+ is currently used by over five thousand JBI member organizations and individuals around the world to inform clinical decision making at the point-of-care.
About Ovid and Lippincott Williams & Wilkins
Ovid is a global information solutions provider offering clinicians, professionals, students, and researchers in the medical, scientific, and academic fields, customizable solutions of content, tools, and services that make research smarter, faster, and more effective. Ovid is used by the world's leading colleges and universities; medical schools; academic research libraries and library consortia; hospitals and healthcare systems; pharmaceutical, engineering and biotechnology companies; and HMOs and clinical practices.
Lippincott Williams & Wilkins (LWW) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1,500 books in more than 100 disciplines publishing under the LWW brand, as well as content-based sites and online corporate and customer services. LWW journals partners with the world's leading medical societies, nursing and health professions associations to help them innovate content strategies in print and online.
Wolters Kluwer Health is a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy, and is part of Wolters Kluwer, a market-leading global information services company. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare rely on Wolters Kluwer's leading, information-enabled tools and solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer has 2009 annual revenues of euro 3.4 billion ($4.8 billion), employs approximately 19,300 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.
|SOURCE Wolters Kluwer Health|
Copyright©2010 PR Newswire.
All rights reserved